Summary
Bruce Downey, Barr's CEO, said last week that the company was "disappointed" by the FDA decision and believes a "a delay is not justified." It will continue to press the agency to approve Plan B for over-the-counter sale.
See the full content of this document
Extract
Morning After More Than a Day Away
The FDA delayed a decision again last week on whether to approve Barr La...
See the full content of this document
Sponsored links
